Mammogen Achieves CLIA Validation of gen-TRU-breast™ Assay

World’s First Early Detection Blood Test to Unlock Stage I Diagnosis of Breast Cancer NEWPORT BEACH, Calif., Nov. 15, 2023 /PRNewswire/ — Mammogen, a leader in women’s health and bellwether subsidiary of early detection parent company IVBH, has announced the successful completion of…

Click here to view original post